Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

CVS Caremark Corporation (CVS): Is Walgreen Company (WAG) Running Out of Fresh Ideas?

In the Fortune interview, Wasson said he picked up a statistic showing that 60% of people don’t know by 10 a.m. what they’re having for dinner that night. He wants to have Walgreen be the place consumers turn to when they’re making those decisions as they’re running through the store to pick up their prescriptions.

I think that’s the fatal flaw in the plan. While the chain may be gaining share and it may see its pharmacy sales rising, lifted in no small part by the explosion of generic drug sales resulting from the pharmaceutical industry falling off the patent cliff, people just don’t pick up prescriptions every day. There’s just not enough of a public perception of Walgreen as a grocery store to make customers go there instead of Kroger, Safeway, or Wal-Mart. And since Express Scripts Holding Company (NASDAQ:ESRX) acquired mail-order drug service Medco, which has also implemented an auto-renewal service for prescriptions, the need to even visit a pharmacy is declining.

That explains why Walgreen needs new ideas to get people into its stores, but with the prospects that its results will wilt like day-old produce when it reports fourth-quarter earnings, I think the best prescription for investors will be to sit on the sidelines for a while.

The article Is Walgreen Running Out of Fresh Ideas? originally appeared on and is written by Rich Duprey.

Fool contributor Rich Duprey has no position in any stocks mentioned. The Motley Fool recommends Express Scripts. The Motley Fool owns shares of Express Scripts.

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.